John F. Crowley - 09 Jan 2024 Form 4 Insider Report for AMICUS THERAPEUTICS, INC. (FOLD)

Signature
/s/ Christian Formica, Attorney-in-Fact
Issuer symbol
FOLD
Transactions as of
09 Jan 2024
Net transactions value
-$934,659
Form type
4
Filing time
11 Jan 2024, 18:33:44 UTC
Previous filing
05 Jan 2024
Next filing
18 Jan 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FOLD Common Stock Tax liability $503,207 -36,865 -3.9% $13.65 901,007 09 Jan 2024 Direct
transaction FOLD Common Stock Sale $431,452 -31,614 -3.5% $13.65 869,393 10 Jan 2024 Direct F1
holding FOLD Common Stock 64,895 09 Jan 2024 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.48 to $13.96 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

All transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2023.